시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
황반변성증 치료 시장 규모, 점유율, 성장 분석 : 유형별, 치료법별, 질병 단계별, 투여 경로별, 지역별 - 산업 예측(2025-2032년)
Macular Degeneration Treatment Market Size, Share, Growth Analysis, By Type, By Treatment, By Stage of Disease, By Route of Administration, By Region - Industry Forecast 2025-2032
상품코드 : 1630592
리서치사 : SkyQuest Technology Consulting Pvt. Ltd.
발행일 : 2025년 01월
페이지 정보 : 영문 157 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,483,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,754,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,025,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계의 황반변성증 치료 시장 규모는 2023년에 167억 달러로 평가되며, 예측 기간(2025-2032년)의 CAGR은 8.5%로 성장하며, 2024년 181억 2,000만 달러에서 2032년에는 348억 달러로 성장할 전망입니다.

세계 황반변성 치료제 시장은 노화 관련 황반변성(AMD)의 유병률 증가와 노인 인구 증가로 인해 빠르게 성장하고 있습니다. 효과적인 치료 솔루션에 대한 수요가 증가하는 가운데, 혁신적인 항VEGF 요법 및 서방형 약물전달 시스템 등 의학 연구의 눈부신 발전으로 환자 예후가 개선되고 있습니다. 주요 시장 동향으로는 여러 질병 경로를 표적으로 하는 병용요법과 유전적 요인을 다루는 유망한 유전자 치료 접근법이 부상하고 있습니다. 그러나 고가의 치료비, 제한된 보험 적용 범위, 까다로운 규제 요건 등의 과제는 여전히 남아있습니다. 주목할 만한 것은 아시아태평양과 라틴아메리카의 신흥 시장에 큰 성장 기회가 있으며, 인공지능과 머신러닝 기술의 통합은 진단과 치료의 강화를 약속하고 맞춤형 의료의 길을 열어줄 것입니다.

목차

서론

조사 방법

개요

시장 역학과 전망

주요 시장 인사이트

황반변성증치료 시장 규모 : 유형별

황반변성증치료 시장 규모 : 치료별

황반변성증치료 시장 규모 : 질병 단계별

황반변성증치료 시장 규모 : 투여 경로별

황반변성증치료 시장 규모 : 유통 채널별

황반변성증치료 시장 규모

경쟁 정보

주요 기업 개요

결론과 권장사항

KSA
영문 목차

영문목차

Global Macular Degeneration Treatment Market size was valued at USD 16.7 billion in 2023 and is poised to grow from USD 18.12 billion in 2024 to USD 34.8 billion by 2032, growing at a CAGR of 8.5% during the forecast period (2025-2032).

The global macular degeneration treatment market is rapidly evolving, driven by the increasing prevalence of age-related macular degeneration (AMD) and a rising elderly population. As the demand for effective therapeutic solutions grows, notable advancements in medical research, including innovative anti-VEGF therapies and sustained-release drug delivery systems, have improved patient outcomes. Key market trends highlight the rise of combination therapies, targeting multiple disease pathways, and promising gene therapy approaches that address genetic factors. However, challenges such as high treatment costs, limited reimbursement coverage, and stringent regulatory requirements persist. Notably, emerging markets in Asia-Pacific and Latin America present significant growth opportunities, while the integration of artificial intelligence and machine learning technologies promises to enhance diagnostics and treatment, paving the way for personalized medicine.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Macular Degeneration Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Macular Degeneration Treatment Market Segmental Analysis

Global Macular Degeneration Treatment Market is segmented by Type, Treatment, Stage of Disease, Route of Administration, Distribution Channel and region. Based on Type, the market is segmented into Dry Age-related Macular Degeneration, Wet Age-related Macular Degeneration and Others. Based on Treatment, the market is segmented into Anti-vascular Endothelial and Others. Based on Stage of Disease, the market is segmented into Early-stage AMD, Intermediate AMD and Late-stage AMD. Based on Route of Administration, the market is segmented into Intravenous Route and Intravitreal Route. Based on Distribution Channel, the market is segmented into Ambulatory Surgical Centres, Hospitals and Other Channels. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Macular Degeneration Treatment Market

The macular degeneration treatment market is significantly influenced by the growing aging population. As macular degeneration predominantly impacts individuals over 50, the rise in the global elderly demographic is anticipated to escalate the incidence of this condition. The World Health Organization has projected that the population aged 60 and above will double by 2050. This demographic transformation is poised to enhance the demand for effective treatments targeting macular degeneration, driving market growth. Consequently, healthcare providers and pharmaceutical companies are increasingly focused on developing innovative therapies to address the needs of this expanding population segment, ultimately fostering advancements in treatment options.

Restraints in the Global Macular Degeneration Treatment Market

The Global Macular Degeneration Treatment market faces several restraints, one of which is the stringent regulatory requirements that govern the industry. The process for obtaining approval for new treatment options is often protracted and can impose significant costs on pharmaceutical companies. This involves extensive clinical trials, rigorous safety assessments, and detailed regulatory submissions, all of which can hinder the timely introduction of novel therapies. Consequently, the intricate regulatory landscape may discourage some companies from investing in research and development for macular degeneration treatments, ultimately restricting the range and availability of innovative solutions for patients suffering from this condition.

Market Trends of the Global Macular Degeneration Treatment Market

The Global Macular Degeneration Treatment market is increasingly influenced by the rise of telemedicine and remote monitoring technologies, which have revolutionized patient care in this sector. The shift towards these digital healthcare solutions facilitates remote assessments of vision and disease progression, minimizing the necessity for frequent in-person consultations. This trend not only enhances patient convenience and compliance but also enables timely interventions and effective disease management, ultimately driving down healthcare costs. Innovations such as home-based visual acuity testing and smartphone imaging devices are becoming integral in monitoring treatment efficacy and disease developments, underscoring a transformative move towards more accessible and efficient care.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Macular Degeneration Treatment Market Size by Type & CAGR (2025-2032)

Global Macular Degeneration Treatment Market Size by Treatment & CAGR (2025-2032)

Global Macular Degeneration Treatment Market Size by Stage of Disease & CAGR (2025-2032)

Global Macular Degeneration Treatment Market Size by Route of Administration & CAGR (2025-2032)

Global Macular Degeneration Treatment Market Size by Distribution Channel & CAGR (2025-2032)

Global Macular Degeneration Treatment Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기